Synthesis and electronic spectra of new low-molecular weight
compounds with possible application in electroluminescent layers
2.3. Synthesis of compound 10
in acetic acid (AcOH) in order to obtain the desired
compound 5 as pure Z isomer [7].
Thepreparation ofcompound 5includes thefollowing
steps (Scheme 1):
Step 1: Preparation of the intermediate (Z)-4-(4-
(dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-
one (3):
A mixture of hippuric acid (1) (2.00 g, 11.2 mmol),
4-(dimethylamino)-benzaldehyde (2) (1.67 g, 11.2 mmol)
and anhydrous KOAc (1.10 g, 11.2 mmol) was refluxed
in 15 mL acetic anhydride for 1 h. After cooling, the
volatile was evaporated at 60°C in vacuo and the crude
intermediate 3 was obtained. This solid was washed with
15 mL hexane in ultrasonic bath and recrystallized from
EtOH:water = 1:1. After drying in vacuo, the oxazolone 3
was used as starting material for the next synthetic step
without characterization.
Compound 10 was synthesized in two steps, as well
(Scheme 2). The first step included preparation by
a known procedure [8] of the intermediate 8, which
does not possess fluorescent properties. The reaction
takes place in refluxing absolute ethanol and does not
affect the bromine atom. In the second step the desired
compound 10 was obtained with excellent yield through
non-catalytic N-arylation of pyrrolidine with compound 8
in boiling DMF [9].
Step 1: Preparation of intermediate 6-bromo-2-(6-
hydroxyhexyl)-1H benzo[de]isoquinoline-1,3(2H)-dione
(8).
A mixture of 6 (1.50 g, 5.41 mmol) and 7 (0.70 g,
5.95 mmol) was refluxed for 4 h in 40 mL absolute EtOH.
After cooling, the reaction mixture was poured into
250 mL 5% aqueous citric acid and stirred overnight.
The obtained white precipitate of the crude product 8
was filtered, washed with water and dried in vacuo. After
purification with flash column chromatography (60 g
silica gel, phase hexane:Et2O = 1:2), the pure product 8
was obtained as white crystals (1.05 g, 51% yield). M.p.
93-94 ºC. 1H-NMR (CDCl3, 600.13 MHz): δ 8.65 (dd, 1H,
10-H), 8.56 (dd, 1H, 8-H), 8.40 (m, 1H, 4-H), 8.04 (m, 1H,
5-H), 7.84 (m, 1H, 9-H), 4.17 (m, 2H, 12-H), 3.65 (q, 2H,
17-H), 1.75 (m, 2H, 13-H), 1.60 (m, 2H, 16-H), 1.41-1.49
(m, 4H, 14-H, 15-H). 13C-NMR (CDCl3, 150.92 MHz): δ
163.63 (s, 1C, C=O), 163.61 (s, 1C, C=O), 133.24 (d,
1C, 8-C), 132.02 (d, 1C, 10-C), 131.21 (d, 1C, 4-C),
131.07 (d, 1C, 5-C), 130.58 (s, 1C, 7-C), 130.23 (s, 1C,
6-C), 128.95 (s, 1C, 7a-C), 128.06 (d, 1C, 9-C), 123.05
(s, 1C, 11-C), 122.19 (s, 1C, 3-C), 62.74 (t, 1C, 17-C),
40.33 (t, 1C, 12-C), 32.56 (t, 1C, 16-C), 27.93 (t, 1C,
13-C), 26.64* (t, 1C, 14-C or 15-C), 25.24* (t, 1C, 14-C
or 15-C). Anal. calcd. for C18H18BrNO3 (Mw =376.24):
C, 57.46; H, 4.82; Br, 21.24; N, 3.72; O, 12.76. Found:
C, 57.40; H, 4.88; Br, 21.30; N, 3.71. MS (EI) m/z (rel.
int.): 376.47 (M+●, 90), 346.27 (16), 304.08 (10), 302.92
(15), 302.06 (11), 290.98 (62), 290.12 (87), 289.04 (78),
277.91 (75), 277.10 (100), 276.04 (99), 260.04 (39),
259.03 (56), 257.98 (30), 232.84 (36), 232.06 (38),
230.04 (17), 197.05 (9), 151.08 (10), 126.04 (15).
Step 2: Preparation of the target product 2-(6-
hydroxyhexyl)-6-(pyrrolidin-1-yl)-1H-benzo[de]
isoquinoline-1,3(2H)-dione (10).
Step 2: Preparation of the target product: (Z)-4-(4-
(dimethylamino)benzylidene)-1-(9-ethyl-9H-carbazol-3-
yl)-2-phenyl-1H-imidazol-5(4H)-one (5):
A mixture of oxazolone (3) (1.46 g, 5.0 mmol),
9-ethyl-9H-carbazol-3-amine (4) (4.21 g, 20.0 mmol)
and KOAc (0.49 g, 5.0 mmol) was refluxed in glacial
acetic acid (20 mL) for 7 h. After cooling, the volatile
was evaporated at 60°C in vacuo. The residue was
washed with 50 mL hexane in ultrasonic bath and dried
in vacuo to obtain the crude product 5. After twofold
flash column chromatography (190 g silica gel, phase:
DCM and DCM:Et2O = 20:1), 1.07 g of pure compound
5 was obtained as orange crystals (44% yield). M.p.
285-286 ºC. 1H-NMR (CDCl3, 250 MHz): δ 8.27 (d,
2H, J = 8.9 Hz), 8.03 (dt, 1H, J = 7.8, 1.0 Hz), 7.98 (m,
1H), 7.63-7.65 (m, 1H), 7.59-7.62 (m, 1H), 7.39-7.55
(overlapping m, 3H), 7.36 (s, 1H), 7.31 (m, 1H), 7.19-
7.27 (overlapping m, 4H), 6.77 (d, 2H, 3`-H, 5`-H, J =
8.9 Hz), 4.39 (q, 2H, 23-H, J = 7.2 Hz), 3.10 (s, 6H,
NMe2), 1.45 (t, 3H, 24-H, J = 7.2 Hz). 13C-NMR (CDCl3,
62.9 MHz): δ 171.41 (s, 1C, C-imidazolone), 157.55
(s, 1C, C-imidazolone), 151.68 (d, 1C, 4`-C), 140.43
(s, 1C, C-N from carbazole), 139.29 (s, 1C, C-N from
carbazole), 134.78 (d, 2C), 130.63 (d, 1C), 130.43 (d,
1C), 129.60 (s, 1C, C-N from carbazole), 129.04 (d,
2C), 128.13 (d, 2C), 126.47 (s, 1C), 126.20 (d, 1C),
125.14 (d, 1C), 123.44 (s, 1C), 122.67 (s, 1C), 122.56
(s, 1C), 120.84 (d, 1C), 119.84 (d, 1C), 119.14 (d, 1C),
111.76 (d, 2C), 109.00 (d, 1C), 108.68 (d, 1C), 40.07
(q, 2C, NMe2), 37.71 (t, 1C, 23-C), 13.84 (q, 1C, 24-C).
Anal. calcd. for C32H28N4O (Mw = 376.24): C, 79.31; H,
5.82; N, 11.56; O, 3.30 %. Found: C, 79.38; H, 5.80; N,
11.49 %. MS (EI) m/z (rel. int.): 485 (47), 484 (M+●, 100),
298 (15), 297 (56), 242 (15), 194 (16), 179 (40), 159
(49), 105 (24).
A mixture of 8 (0.554 g, 1.47 mmol) and pyrrolidine
(9) (1.22 mL, 14.72 mmol) was refluxed for 1.5 h
in 25 mL dry DMF. The orange solution was cooled,
poured into 200 mL saturated aqueous citric acid and
stirred overnight. The obtained orange precipitate of
the crude product 10 was filtered, washed with water
and dried in vacuo. After purification with column
1128